Literature DB >> 27924720

N-Terminal Pro-B-Type Natriuretic Peptide and Subclinical Brain Damage in the General Population.

Hazel I Zonneveld1, M Arfan Ikram1, Albert Hofman1, Wiro J Niessen1, Aad van der Lugt1, Gabriel P Krestin1, Oscar H Franco1, Meike W Vernooij1.   

Abstract

Purpose To investigate the association between N-terminal pro-B-type natriuretic peptide (NT-proBNP), which is a marker of heart disease, and markers of subclinical brain damage on magnetic resonance (MR) images in community-dwelling middle-aged and elderly subjects without dementia and without a clinical diagnosis of heart disease. Materials and Methods This prospective population-based cohort study was approved by a medical ethics committee overseen by the national government, and all participants gave written informed consent. Serum levels of NT-proBNP were measured in 2397 participants without dementia or stroke (mean age, 56.6 years; age range, 45.7-87.3 years) and without clinical diagnosis of heart disease who were drawn from the population-based Rotterdam Study. All participants were examined with a 1.5-T MR imager. Multivariable linear and logistic regression analyses were used to investigate the association between NT-proBNP level and MR imaging markers of subclinical brain damage, including volumetric, focal, and microstructural markers. Results A higher NT-proBNP level was associated with smaller total brain volume (mean difference in z score per standard deviation increase in NT-proBNP level, -0.021; 95% confidence interval [CI]: -0.034, -0.007; P = .003) and was predominantly driven by gray matter volume (mean difference in z score per standard deviation increase in NT-proBNP level, -0.037; 95% CI: -0.057, -0.017; P < .001). Higher NT-proBNP level was associated with larger white matter lesion volume (mean difference in z score per standard deviation increase in NT-proBNP level, 0.090; 95% CI: 0.051, 0.129; P < .001), with lower fractional anisotropy (mean difference in z score per standard deviation increase in NT-proBNP level, -0.048; 95% CI: -0.088, -0.008; P = .019) and higher mean diffusivity (mean difference in z score per standard deviation increase in NT-proBNP level, 0.054; 95% CI: 0.018, 0.091; P = .004) of normal-appearing white matter. Conclusion In community-dwelling persons, higher serum NT-proBNP levels are associated with volumetric and microstructural MR imaging markers of subclinical brain damage. © RSNA, 2016 Online supplemental material is available for this article.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27924720     DOI: 10.1148/radiol.2016160548

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  13 in total

1.  High-Sensitive Troponin T, Natriuretic Peptide, and Cognitive Change.

Authors:  Yashashwi Pokharel; Farah Mouhanna; Andrea L C Schneider; Andreea M Rawlings; David S Knopman; Vijay Nambi; Salim S Virani; Ron C Hoogeveen; Alvaro Alonso; Gerardo Heiss; Josef Coresh; Thomas Mosley; Rebecca Gottesman; Elizabeth Selvin; Christie Ballantyne; Melinda C Power
Journal:  J Am Geriatr Soc       Date:  2019-07-30       Impact factor: 5.562

2.  The Rotterdam Study: 2018 update on objectives, design and main results.

Authors:  M Arfan Ikram; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2017-10-24       Impact factor: 8.082

3.  High-sensitivity cardiac troponin T and severity of cerebral white matter lesions in patients with acute ischemic stroke.

Authors:  Regina von Rennenberg; Bob Siegerink; Ramanan Ganeshan; Kersten Villringer; Wolfram Doehner; Heinrich J Audebert; Matthias Endres; Christian H Nolte; Jan F Scheitz
Journal:  J Neurol       Date:  2018-10-11       Impact factor: 4.849

4.  Heart Failure and Cognitive Impairment in the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Lucy S Witt; Jason Rotter; Sally C Stearns; Rebecca F Gottesman; Anna M Kucharska-Newton; A Richey Sharrett; Lisa M Wruck; Jan Bressler; Carla A Sueta; Patricia P Chang
Journal:  J Gen Intern Med       Date:  2018-07-20       Impact factor: 5.128

5.  Cognitive Function and Cardiometabolic-Inflammatory Risk Factors Among Older Indians and Americans.

Authors:  Peifeng Hu; Jinkook Lee; Sidney Beaumaster; Jung Ki Kim; Sharmistha Dey; David Weir; Eileen M Crimmins
Journal:  J Am Geriatr Soc       Date:  2020-08       Impact factor: 5.562

6.  Change in NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Level and Risk of Dementia in Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Mohammad R Ostovaneh; Kasra Moazzami; Kihei Yoneyama; Bharath A Venkatesh; Susan R Heckbert; Colin O Wu; Steven Shea; Wendy S Post; Annette L Fitzpatrick; Gregory L Burke; Hossein Bahrami; Otto A Sanchez; Lori B Daniels; Erin D Michos; David A Bluemke; João A C Lima
Journal:  Hypertension       Date:  2019-12-23       Impact factor: 10.190

7.  PANDORA'S BOX.

Authors: 
Journal:  BJPsych Int       Date:  2017-05-01

8.  NT-proBNP and Risk of Dementia in a General Japanese Elderly Population: The Hisayama Study.

Authors:  Takuya Nagata; Tomoyuki Ohara; Jun Hata; Satoko Sakata; Yoshihiko Furuta; Daigo Yoshida; Takanori Honda; Yoichiro Hirakawa; Tomomi Ide; Shigenobu Kanba; Takanari Kitazono; Hiroyuki Tsutsui; Toshiharu Ninomiya
Journal:  J Am Heart Assoc       Date:  2019-08-24       Impact factor: 5.501

9.  Subclinical Cardiac Dysfunction and Brain Health in Midlife: CARDIA (Coronary Artery Risk Development in Young Adults) Brain Magnetic Resonance Imaging Substudy.

Authors:  Pavla Cermakova; Majon Muller; Anderson C Armstrong; Dorota Religa; R Nick Bryan; João A C Lima; Lenore J Launer
Journal:  J Am Heart Assoc       Date:  2017-12-15       Impact factor: 5.501

10.  N-Terminal pro-Brain Natriuretic Peptide and Associations With Brain Magnetic Resonance Imaging (MRI) Features in Middle Age: The CARDIA Brain MRI Study.

Authors:  Ian T Ferguson; Martine Elbejjani; Behnam Sabayan; David R Jacobs; Osorio Meirelles; Otto A Sanchez; Russell Tracy; Nick Bryan; Lenore J Launer
Journal:  Front Neurol       Date:  2018-05-07       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.